CSIMarket
 


Nuvation Bio Inc   (NUVB)
Other Ticker:  
 

Nuvation Bio Inc 's Leverage Ratio

NUVB's quarterly Leverage Ratio and Total Liabilities, Equity growth




NUVB Leverage Ratio (Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Equity Change -13.18 % -12.15 % -10.27 % 14819.92 % -
Y / Y Total Liabilities Change -34.73 % 5.26 % 9.83 % -78.45 % -
Leverage Ratio MRQ 0.03 0.04 0.04 0.04 0.04
Overall Ranking # # # # #
Seq. Equity Change -3.63 % -4.21 % -3.01 % -3.04 % -2.48 %
Seq. Total Liabilities Change -30.4 % -5.61 % -6.34 % 6.08 % 12.23 %



Leverage Ratio third quarter 2022 Comment
Due to repayements of liabilities of -30.4% Nuvation Bio Inc improved Leverage Ratio in third quarter 2022 to 0.03, above company's average Leverage Ratio.

Within Major Pharmaceutical Preparations industry Nuvation Bio Inc achieved lowest Leverage Ratio. While total ranking remained unchanged compare to previous quarter at no. .

Explain Leverage Ratio?
Who are NUVB Customers?
Leverage Ratio third quarter 2022 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #


Leverage Ratio Statistics
High Average Low
0 0 0
 




Financial Statements
Nuvation Bio Inc 's Equity $ 668 Millions Visit NUVB's Balance sheet
Nuvation Bio Inc 's Total Liabilities $ 19 Millions Visit NUVB's Balance sheet
Source of NUVB's Sales Visit NUVB's Sales by Geography


Cumulative Nuvation Bio Inc 's Leverage Ratio

NUVB's Leverage Ratio for the trailling 12 Months

NUVB Leverage Ratio

(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Equity TTM Growth -13.18 % -12.15 % -10.27 % 14819.92 % -
Y / Y Total Liabilities TTM Growth -34.73 % 5.26 % 9.83 % -78.45 % -
Leverage Ratio TTM 0.04 0.04 0.04 0.04 0.09
Total Ranking TTM # 42 # 74 # 73 # 72 # 218
Seq. Equity TTM Growth -3.63 % -4.21 % -3.01 % -3.04 % -2.48 %
Seq. Total Liabilities TTM Growth -30.4 % -5.61 % -6.34 % 6.08 % 12.23 %


TTM Leverage Ratio Comment
On the trailing twelve months basis Due to repayements of liabilities of -30.4% Nuvation Bio Inc has not changed Leverage Ratio in the III. Quarter to 0.04, a new company low.
Leverage Ratio is the average cumulative value over the last four quarters.

Among companies in the Major Pharmaceutical Preparations industry 10 other companies have achieved lower Leverage Ratio than Nuvation Bio Inc . While Leverage Ratio total ranking has improved so far to 0, from total ranking in previous quarter at 71.

Explain Leverage Ratio?
Who are NUVB Customers?

TTM Leverage Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 11
Healthcare Sector # 13
Within the Market # 42


TTM Leverage Ratio Statistics
High Average Low
0.21 0.07 0.04
(Jun 30 2021)   (Dec 31 2021)




Companies with similar Leverage Ratio in the quarter ending Sep 30 2022, within Major Pharmaceutical Preparations Industry Leverage RatioSep 30 2022 MRQ Total LiabilitiesSep 30 2022 MRQ Equity
Kezar Life Sciences Inc   0.08 $ 21.582  Millions$ 283.188  Millions
Anebulo Pharmaceuticals Inc  0.07 $ 1.396  Millions$ 19.117  Millions
Ainos Inc   0.07 $ 2.656  Millions$ 36.426  Millions
Chimerix inc   0.07 $ 19.928  Millions$ 273.952  Millions
Xenetic Biosciences Inc   0.07 $ 1.051  Millions$ 14.522  Millions
Anaptysbio inc  0.07 $ 19.459  Millions$ 277.619  Millions
Medicinova Inc   0.07 $ 5.084  Millions$ 73.106  Millions
Olema Pharmaceuticals inc   0.07 $ 14.298  Millions$ 217.699  Millions
Guardion Health Sciences Inc   0.07 $ 1.724  Millions$ 26.495  Millions
Syndax Pharmaceuticals Inc   0.06 $ 21.585  Millions$ 338.102  Millions
Oramed Pharmaceuticals Inc   0.06 $ 9.636  Millions$ 153.147  Millions
Annovis Bio inc   0.06 $ 1.846  Millions$ 29.961  Millions
Astria Therapeutics inc   0.06 $ 6.945  Millions$ 112.872  Millions
Pasithea Therapeutics Corp   0.06 $ 2.819  Millions$ 46.789  Millions
Eledon Pharmaceuticals Inc   0.06 $ 8.493  Millions$ 141.093  Millions
Tonix Pharmaceuticals Holding Corp   0.06 $ 13.722  Millions$ 228.924  Millions
Pardes Biosciences Inc   0.06 $ 12.028  Millions$ 202.013  Millions
Morphic Holding inc   0.06 $ 20.775  Millions$ 365.061  Millions
Io Biotech Inc   0.06 $ 8.668  Millions$ 153.489  Millions
Catalyst Biosciences Inc   0.06 $ 1.644  Millions$ 29.375  Millions
Nuvalent Inc   0.05 $ 12.975  Millions$ 236.583  Millions
Kura Oncology Inc   0.05 $ 22.983  Millions$ 419.621  Millions
Point Biopharma Global Inc   0.05 $ 16.608  Millions$ 309.080  Millions
Forte Biosciences Inc   0.05 $ 2.293  Millions$ 42.835  Millions
Theseus Pharmaceuticals inc   0.05 $ 11.699  Millions$ 218.594  Millions
Day One Biopharmaceuticals Inc   0.05 $ 18.785  Millions$ 363.076  Millions
Lantern Pharma Inc   0.05 $ 3.047  Millions$ 59.025  Millions
Zomedica Corp   0.05 $ 13.518  Millions$ 268.781  Millions
Cyteir Therapeutics Inc   0.05 $ 7.663  Millions$ 154.033  Millions
Terns Pharmaceuticals Inc   0.05 $ 8.892  Millions$ 183.694  Millions

Date modified: 2022-11-06T03:44:33+00:00

Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

ACM's Profile

Stock Price

ACM's Financials

Business Description

Fundamentals

Charts & Quotes

ACM's News

Suppliers

ACM's Competitors

Customers & Markets

Economic Indicators

ACM's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071